I have been following this company for about 10 years. They use to be known as synthetic blood inc, now they are known as oxygen biotherapeutics. The company has been doing some studies for TBI, trauma, surgery, AMI, sickle cell crisis, decompression sickness etc. with this product.
http://www.oxybiomed.com/index.html
Oxycyte is the company’s perfluorocarbon (PFC) therapeutic oxygen carrier. It is designed to enhance oxygen delivery to damaged tissues. When used as an intravenous emulsion, Oxycyte can carry as much as five times more oxygen than hemoglobin, making it an effective means of transporting oxygen to tissues and carrying carbon dioxide to the lungs for disposal. Oxycyte is not a blood substitute. Because it is a PFC, and not based on hemoglobin, it does not have the safety issues associated with hemoglobin-based products. In fact, there have been no adverse events in company clinical trials that were related to Oxycyte.